NCT00189163View on ClinicalTrials.gov

Pioglitazone in Hepatitis C

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2007

Conditions
Chronic Hepatitis C
Interventions
DRUG

Pioglitazone

30 mg, taken orally, once per day, for 48 weeks

DRUG

Placebo Oral Tablet

Sugar Pill, taken orally, once per day, for 48 weeks

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT00189163 - Pioglitazone in Hepatitis C | Biotech Hunter | Biotech Hunter